M. Fantini

发表

Further observations on carbamazepine plasma levels in epileptic patients

R. Mutani, L. Durelli, W. Troni, 1976, Neurology.

Lipoplatin Treatment in Lung and Breast Cancer

L. Gianni, M. Fantini, A. Ravaioli, 2010, Chemotherapy research and practice.

Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer’s Disease

D. Muresanu, M. Fantini, H. Moessler, 2020, The international journal of neuropsychopharmacology.

Outcome research in palliative care: could it represent a new dimension of clinical research or clinical practice?

M. Maltoni, M. Fantini, A. Ravaioli, 2005, Supportive Care in Cancer.

Target therapies in palliative care: from a clinical to a biological approach.

M. Maltoni, M. Fantini, A. Ravaioli, 2004, Journal of pain and symptom management.

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study

M. Campiglio, S. Ménard, P. Querzoli, 2011, Breast Cancer Research and Treatment.

Efficacy of Two Different Platinum- or Anthracycline- Containing Chemotherapy Regimens for the Treatment of Small Cell Lung Cancer

M. Papi, M. Fantini, D. Tassinari, 2005, Journal of chemotherapy.

Is Lipoplatinum Monotherapy an Active Alternative in Second Line Treatment of Metastatic Non–Small Cell Lung Cancer? A Phase II Trial

M. Marangolo, M. Papi, L. Gianni, 2009 .

Lipoplatin™ Monotherapy: A Phase II Trial of Second-Line Treatment of Metastatic Non-Small-Cell Lung Cancer

M. Marangolo, M. Papi, L. Gianni, 2009, Journal of chemotherapy.

Outcomes of palliative chemotherapy in stage IV non-small cell lung cancer. Have we found what we are looking for?

M. Papi, M. Fantini, A. Ravaioli, 2004, Lung cancer.

Quality of care at the end of life: how far are we from reaching a comprehensive solution to the problem?

M. Fantini, D. Tassinari, S. Sartori, 2005, Palliative medicine.

A Month-by-Month Long-Term Study on Carbamazepine: Clinical, EEG and Pharmacological Evaluation

A. Baruzzi, P. Morselli, F. Monaco, 1979, The Journal of international medical research.

Zoledronic acid treatment at home: safety data from an observational prospective trial.

M. Fantini, D. Tassinari, S. Sartori, 2007, Journal of palliative medicine.

Quality of care in clinical oncology: from the dreamworld to the real world of outcome assessment.

M. Fantini, D. Tassinari, S. Sartori, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Can we really consider quality of life as an outcome of palliative care? Author's response

M. Maltoni, I. Higginson, M. Fantini, 2003 .

Treating sialorrhea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients

M. Fantini, D. Tassinari, S. Sartori, 2005, Supportive Care in Cancer.

Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio

A. Miserocchi, F. Recine, M. Burgio, 2021, Frontiers in Immunology.

Carboplatin and Gemcitabine in the Palliative Treatment of Stage IV Non-Small Cell Lung Cancer: Definitive Results of a Phase II Trial

M. Papi, G. Oliverio, S. Pulini, 2004, Tumori.

Small cell neuroendocrine tumor of the breast in a 40 year-old woman: a case report

M. Papi, M. Fantini, A. Ravaioli, 2010, Journal of medical case reports.

Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.

R. Gelber, A. Goldhirsch, A. Coates, 2009, European journal of cancer.

Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report

L. Gianni, M. Fantini, A. Ravaioli, 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Adjuvant treatments in pancreatic cancer: Preliminary data of a pooled analysis.

M. Papi, L. Gianni, M. Fantini, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First prospective data on breast cancer patients from the multicentre italian bone metastasis database

F. Recine, R. Berardi, L. Gurrieri, 2021, Scientific Reports.

Trastuzumab-related thrombocytopenia: always a self-limiting complication?

L. Gianni, M. Fantini, F. Drudi, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Triple Negative Breast Cancer Treatment: Use of Platinum and Platinum Analogs

L. Gianni, M. Fantini, A. Ravaioli, 2012 .

reportSmall cell neuroendocrine tumor of the breast in a 40 year-old woman : a case report

M. Papi, M. Fantini, A. Ravaioli, 2015 .

Can we really consider quality of life as an outcome of palliative care?

M. Maltoni, M. Fantini, A. Ravaioli, 2003, Journal of pain and symptom management.

Aromatase inhibitors and anti-synthetase syndrome

L. Gianni, M. Fantini, A. Affatato, 2016, International journal of immunopathology and pharmacology.

Antimetabolites in the treatment of advanced pleural mesothelioma: a network meta-analysis of randomized clinical trials

M. Papi, M. Fantini, F. Drudi, 2017, Journal of chemotherapy.

Cost-opportunity analysis in clinical oncology: from the 'wild far-west' to a correct integration of the disciplines, avoiding the 'war of the worlds'.

M. Fantini, D. Tassinari, S. Sartori, 2006, Annals of Oncology.

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study

M. Campiglio, S. Ménard, P. Querzoli, 2011, Breast Cancer Research and Treatment.